A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
Qing-Yun Chong, Ze-Hui Kok, Ngoc-Linh-Chi Bui, Xiaoqiang Xiang, Andrea Li‐Ann Wong, Wei Peng Yong, Gautam Sethi, Peter E. Lobie, Lingzhi Wang, Boon-Cher Goh
Topics & Concepts
PalbociclibCyclin-dependent kinaseCDK inhibitorCyclin-dependent kinase 4KinaseBreast cancerMedicineCancerPharmacologyCyclin-dependent kinase 6Cancer researchFulvestrantCell cycleEstrogen receptorMetastatic breast cancerInternal medicineOncologyBiologyCyclin-dependent kinase 2BiochemistryAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysHER2/EGFR in Cancer Research